Genenta Science S.p.A. (GNTA)
GNTA Stock Price Chart
Explore Genenta Science S.p.A. interactive price chart. Choose custom timeframes to analyze GNTA price movements and trends.
GNTA Company Profile
Discover essential business fundamentals and corporate details for Genenta Science S.p.A. (GNTA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Dec 2021
Employees
13.00
Website
https://www.genenta.comCEO
Pierluigi Paracchi
Description
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
GNTA Financial Timeline
Browse a chronological timeline of Genenta Science S.p.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.27.
Earnings released on 31 Mar 2026
EPS came in at -$0.36 matching the estimated -$0.36.
Earnings released on 25 Feb 2026
EPS came in at -$0.36 matching the estimated -$0.36.
Earnings released on 28 Mar 2025
Earnings released on 30 Jun 2024
EPS came in at -$0.24 .
Earnings released on 24 Apr 2024
EPS came in at -$0.30 surpassing the estimated -$0.42 by +29.66%, while revenue for the quarter reached $5.52m .
Earnings released on 30 Jun 2023
EPS came in at -$0.40 surpassing the estimated -$0.41 by +3.25%.
Earnings released on 26 Apr 2023
EPS came in at -$0.38 .
Earnings released on 7 Oct 2022
EPS came in at -$0.12 .
Earnings released on 4 May 2022
EPS came in at -$0.11 .
Earnings released on 15 Dec 2021
EPS came in at -$0.33 .
GNTA Stock Performance
Access detailed GNTA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
